Bibliography
- Romera I, Perez V, Manuel Menchon J, Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study. J Affect Disord 2012; In press
- Fava M. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression. J Clin Psychiatry 2003;64(Suppl 13):26-9
- Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res 2003;12:34-43
- Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993;153:2474-80
- Rush AJ, Trivedi MH, Wisniewski SR, Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17
- Bair MJ, Robinson RL, Katon W, Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-45
- Pae CU, Forbes A, Patkar AA. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs 2011;25:109-27
- American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 2000;157:1-45
- Szegedi A, Muller MJ, Anghelescu I, Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. J Clin Psychiatry 2003;64:413-20
- Posternak MA, Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 2005;66:148-58
- Nierenberg AA, Farabaugh AH, Alpert JE, Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry 2000;157:1423-8
- Romera I, Perez V, Menchon JM, Early switch strategy in patients with major depressive disorder: a double-blind, randomized study. J Clin Psychopharmacol 2012;32:479-86
- Nierenberg AA, McLean NE, Alpert JE, Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 1995;152:1500-3
- Papakostas GI, Petersen T, Sklarsky KG, Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. Psychiatry Res 2007;149:195-200
- Taylor MJ, Freemantle N, Geddes JR, Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006;63:1217-23
- Muzina DJ, Chambers JS, Camacho TA, Adjunctive aripiprazole for depression: predictive value of early assessment. Am J Manag Care 2011;17:793-801
- Paykel ES, Ramana R, Cooper Z, Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25:1171-80
- Rush AJ, Warden D, Wisniewski SR, STAR*D: revising conventional wisdom. CNS Drugs 2009;23:627-47
- Greco T, Eckert G, Kroenke K. The outcome of physical symptoms with treatment of depression. J Gen Intern Med 2004;19:813-18